Oregon’s Medicaid PDL: Will an Evidence-Based Formulary with Voluntary Compliance Set a Precedent for Medicaid?
This report is a case study of Oregon’s experience with its new prescription drug policy in its Medicaid fee-for-service pharmacy program. The report describes Oregon’s clinical review process, and assesses the results relative to other state preferred drug lists.
Report (.pdf)
